Biotech: Pressemitteilungen - Kategorie - Seite 224

Biotech

Category / Pharmaceuticals & Biotech / Biotech


With Final Documentation Submitted for International Patent Applications, Bionor Sees Promise of Two Core Platform Technologies

OSLO, NORWAY: OSLO, NORWAY -- (Marketwire) -- 01/23/12 --Bionor Pharma ASA (OSLO: BIONOR) today announced that its submission has been completed for two applications of Intellectual Property that will provide gener ...

The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With App Pharmaceuticals

PARSIPPANY, NJ: PARSIPPANY, NJ -- (Marketwire) -- 01/23/12 -- The Medicines Company (NASDAQ: MDCO) today announced that it has settled the lawsuits filed by MDCO in the U.S. District Court for the District of Delawa ...

Cellceutix Featured on Cover of Prominent Business Journal

BEVERLY, MA: BEVERLY, MA -- (Marketwire) -- 01/23/12 -- Cellceutix Corporation (OTCBB: CTIX) ("the Company"), a biopharmaceutical company focused on discovering and developing small molecule drugs to t ...

Marina Biotech Receives Notice of Acceptance for Patent Broadly Covering Its Unlocked Nucleobase Analog (UNA) Technology

BOTHELL, WA: Patent Protects Use of UNAs in Multiple Nucleic Acid Constructs Including siRNAs, microRNA Mimics, Antagomirs and Single-Stranded Constructs ...

Helix BioPharma Corp. Responds to Dissident Proxy Circular in Connection With the January 30, 2012 Shareholder Meeting

AURORA, ON: AURORA, ON -- (Marketwire) -- 01/23/12 -- Helix BioPharma Corp. ("Helix" or the "Company") (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP) today announced that it has responded to th ...

PharmaGap Completes $231,000 Private Placement

OTTAWA, ONTARIO: OTTAWA, ONTARIO -- (Marketwire) -- 01/20/12 -- PharmaGap Inc. (TSX VENTURE: GAP)(OTCBB: PHRGF) ("PharmaGap" or "the Company") announced today that it has completed a private offe ...

Miraculins Announces Shares for Debt Transaction

WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwire) -- 01/20/12 -- Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on developing and commercializing diagnostic tests and risk assessment tech ...

NuPathe Announces Allowance of Additional U.S. Patent Application for Its Migraine Patch

CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwire) -- 01/19/12 -- Inc. (NASDAQ: PATH), an emerging biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of t ...

Sernova Receives Patent Allowance in Japan

LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 01/19/12 -- Sernova Corp. (TSX VENTURE: SVA), today announced that the Japan Patent Office has issued a Notice of Allowance to Sernova for a patent entitled " ...

Aptalis Pharma Announces FDA Approval of NDA for Oral Powder Formulation of Viread(R), Co-Developed With Gilead Sciences, Inc.

BRIDGEWATER, NJ: BRIDGEWATER, NJ -- (Marketwire) -- 01/18/12 -- Aptalis Pharma, a global specialty pharmaceutical company focused on gastrointestinal diseases and cystic fibrosis, today announced that the U.S. Food a ...

The Medicines Company's Cangrelor Bridge Trial Published in the Journal of the American Medical Association

PARSIPPANY, NJ: PARSIPPANY, NJ -- (Marketwire) -- 01/17/12 -- The Medicines Company (NASDAQ: MDCO) today announced publication in the Journal of the American Medical Association (JAMA) of clinical trial results fro ...

American Pharmaceutical Review Announces Launch of Redesigned Website

SOUTH SAN FRANCISCO, CA: Redesign Strengthens Resource for Pharmaceutical Professionals and Drives Value for Advertisers ...

Cleveland BioLabs Publishes Manuscript on New Radiation Countermeasure CBLB613

BUFFALO, NY: BUFFALO, NY -- (Marketwire) -- 01/17/12 -- (NASDAQ: CBLI) today announced the online publication of a manuscript describing the radioprotective and radiomitigating properties of a new countermeasur ...

Miraculins Files with Health Canada for PreVu Medical Device License

WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwire) -- 01/17/12 -- Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on developing and commercializing diagnostic tests and risk assessment tech ...

ISTA Pharmaceuticals Announces Adoption of a Replacement Stockholders Rights Plan

IRVINE, CA: IRVINE, CA -- (Marketwire) -- 01/17/12 -- ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced that its Board of Directors, in the best interests of the Company and shareholders, has adopted a ...

Aeolus to Present at the Noble Financial Capital Markets' 8th Annual Equity Conference

MISSION VIEJO, CA: MISSION VIEJO, CA -- (Marketwire) -- 01/17/12 -- Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant government funding to develop a platfor ...

Cellceutix Anti-Cancer Drug Shown to Regulate HDAC2, a Major Therapeutic Target for Treatment of a Broad Range of Cancers

BEVERLY, MA: Potent Anticancer Activity Demonstrated in a Wide Range of Tumor Types as Kevetrin(TM) Targets a Histone Deacetylase ...

Helix BioPharma Corp. Announces Q1 2012 Results

AURORA, ON: AURORA, ON -- (Marketwire) -- 01/13/12 -- Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment ...


Seite 224 von 255:  « ..  223 224 225  226  227  228  229  230  231  232  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z